Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
03/2007
03/08/2007WO2007026313A2 4-aminophenol derivatives and colorants comprising these compounds
03/08/2007WO2006103401A3 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
03/08/2007WO2006090289A8 Compounds for reducing aggregation of amyloid beta-peptide
03/08/2007US20070054904 Phenol derivatives and their use as rotamase inhibitors
03/08/2007US20070054888 Novel substituted diamine derivatives useful as motilin agonists
03/08/2007CA2621189A1 Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators
03/07/2007EP1760067A2 Compounds with protected hydroxy groups
03/07/2007EP1759713A2 Lock and key micelles
03/07/2007EP1368304B1 Prodrugs of excitatory amino acids
03/07/2007EP1047645B1 Compound for use as a mineral fibre binder and process for providing such
03/07/2007EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
03/07/2007CN1926091A Process for the carbonylation of ethylenically or acetylenically unsaturated compounds
03/07/2007CN1923797A Pharmaceutical compounds
03/07/2007CN1923790A Kutkin derivative, preparation method and application thereof
03/06/2007US7186862 Phytopathogenic fungicides for Xanthomonas, Pseudomonas, Erwinia, Erysiphe, Sphaerotheca, Podosphaera, Cochliobolus, Uromyces, Puccinia, Tilletia, Ustilago, Pellicularia, Leptosphaeria, and Alternaria species
03/06/2007US7186861 Z-substituted acrylamides, methods for production thereof and agents comprising the same
03/06/2007US7186846 Process for preparing a dipeptidyl peptidase IV inhibitor and intermediates employed therein
03/06/2007US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents
03/06/2007US7186735 Vasodilation; cardiovascular disorders; anticoagulants
03/06/2007US7186414 Improved bioavailability; for oral and intracolonic administration
03/06/2007CA2277913C New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
03/06/2007CA2213119C Highly polymerizable n-vinylcarboxylic acid amide and production process thereof
03/01/2007WO2006135694A3 Uii-modulating compounds and their use
03/01/2007WO2006087324A3 Method for producing an n-(1-aryl-alk-1-enyl)-acetamide or n-(1-heteroaryl-alk-1-enyl)-acetamide
03/01/2007WO2005030711A3 Bridged macrocyclic module compositions
03/01/2007US20070049773 Process for functionalising a phenolic compound carrying an electron-donating group
03/01/2007US20070049728 Solid phase synthesis supports and methods
02/2007
02/28/2007EP1757595A1 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof
02/28/2007EP1756131A2 Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts
02/28/2007EP1756081A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
02/28/2007EP1756041A2 Polycationic compounds and uses thereof
02/28/2007EP1756040A1 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
02/28/2007EP1756039A2 Compounds and compositions for delivering active agents
02/28/2007EP1756036A1 Indene derivatives and process for the preparation thereof
02/28/2007EP1755572A2 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators
02/28/2007EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
02/28/2007EP1265606B9 Cell adhesion inhibitors
02/28/2007CN1922216A Styrene derivative, styrene polymer, photosensitive resin composition, and method for forming pattern
02/28/2007CN1922165A 3-(4-benzyloxyphenyl)propanoic acid derivative
02/28/2007CN1922143A Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
02/28/2007CN1922133A Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
02/28/2007CN1302116C Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative
02/28/2007CN1301982C Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
02/28/2007CN1301974C Muller Klaus-helmut
02/28/2007CN1301964C Inhibitors of alpha 4 mediated cell adhesion
02/28/2007CN1301961C Method for preparing of cationic surfactants and fabric softener composition using the same
02/27/2007US7183440 Pharmaceutically useful compounds
02/27/2007US7183433 Ionic liquids and their use as solvents
02/27/2007US7183432 Synthesis of ynamides
02/27/2007US7183431 Dihydroxy aromatic compounds and methods for preparation
02/27/2007US7183430 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same
02/27/2007US7183426 T-butyl cascade polymers
02/27/2007US7183417 Which has antitumor activity; starting from (2S, 3R)-methyl 2-(4-methoxybenzamido)-3-hydroxybutanoate and cyclizing to Methyl 4,5-dihydro-2 (4-methoxyphenyl)-5-methyloxazole-4-carboxylate
02/27/2007US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/22/2007WO2007021067A1 Hydroxybenzamide derivatives, the method for preparing thereof and the cosmetic composition containing the same
02/22/2007WO2007020227A1 Method for producing betamimetics
02/22/2007WO2007019752A1 Process for the preparation of gabapentin hydrochloride
02/22/2007US20070043242 Method for producing deuterated methyl methacrylate
02/22/2007US20070043213 Photo-initiated carbonylation with carbon-isotope labeled carbon monoxide using amines and alkyl/aryl iodides; carbon-isotope labeled amides are useful as radiopharmaceuticals, especially for use in Positron Emission Tomography
02/22/2007US20070043117 preparation of chirally pure nateglinide by treating a lower alkyl ester thereof with a base to yield an alkali salt and liberating the product from said salt by proper addition of an acid
02/22/2007US20070043113 Novel compounds
02/22/2007US20070043011 Substituted benzanilide compound and noxious organism controlling agent
02/22/2007CA2619402A1 Method for producing betamimetics
02/21/2007EP1753733A1 Small molecules for treatment of hypercholesterolemia and related diseases
02/21/2007EP1753717A1 Method for producing diphenyl azetidinone derivatives
02/21/2007EP1753713A2 Synthesis of tetracyclines and analogues thereof
02/21/2007EP1539676A4 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom
02/21/2007EP0870014B1 Aldolase catalytic antibody
02/21/2007CN1918136A Dehydrating condensation agent having property of accumulating at interface with water
02/21/2007CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same
02/21/2007CN1918111A Formulation auxiliary agents
02/21/2007CN1918087A Method for selective reduction of aromatic compounds
02/21/2007CN1917870A Compounds and compositions as lxr modulators
02/21/2007CN1915967A Method for preparing purified capsicine of monomer
02/21/2007CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/21/2007CN1301210C Preparation of safety brominized reagent
02/20/2007US7179943 N-[3,5-bis(trifluoromethyl)phenyl]-1,8,8-trimethyl-2,4-dioxobicyclo[3.2.1]octane-3-carboxamide; treating convulsions, epilepsy, episodic ataxia, myokymia, neonatal convulsions, cerebral ischemia, cerebral palsy, stroke, traumatic brain injury, traumatic spinal cord injury
02/20/2007US7179942 Halo-substituted active methylene compounds
02/20/2007US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
02/20/2007US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid
02/20/2007US7179794 Antibiotics; bactericides
02/20/2007US7179783 Sulfuric acid amine salt, sulfonic acid amine salt, production thereof and softener composition
02/20/2007CA2085192C Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones
02/15/2007WO2007019210A1 Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives
02/15/2007WO2007018279A1 Process for producing high-purity n-vinylcarboxamides
02/15/2007WO2007017670A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
02/15/2007WO2007017092A1 Substituted 4-benzyloxy-benzoic acid amide derivatives
02/15/2007US20070037985 Hydrogenating a corresponding nitroarene or nitroheteroarene with formic acid and/or ammonium formate as hydrogen donor and formylating agent in the presence of at least one noble metal-based hydrogenation catalyst and a vanadium or molybdenum compound as co-catalyst
02/15/2007US20070037976 Method for producing an optically active nitro compound
02/15/2007US20070037830 2-Adamantyl derivatives as p2X7 receptor antagonists.
02/15/2007US20070036876 Relieving pain at a body site by administering a dosage of capsaicinoid at the painful site without eliciting an effect outside the discrete location; local anesthetic effect; targeted therapy
02/15/2007DE19648513B4 Verfahren zur Herstellung von hochreinem Alkanolamid A process for the production of high purity alkanolamide
02/15/2007CA2618486A1 Ep2 receptor agonists
02/15/2007CA2618089A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
02/15/2007CA2616214A1 Management of ophthalmologic disorders, including macular degeneration
02/14/2007EP1752445A1 New crystalline form III of agometalin, the process for its preparation and pharmaceutical compositions containing it
02/14/2007EP1752444A1 New crystalline form IV of agometaline, the process for making it and pharmaceutical compositions containing it
02/14/2007EP1752443A1 New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it
02/14/2007EP1751206A2 Polyurea compositions and compounds for the preparation thereof
02/14/2007EP1751092A1 Organic activator
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 289